Breaking News Instant updates and real-time market news.

IBB

iShares Nasdaq Biotechnology Index

$117.24

0.7 (0.60%)

06:48
08/15/18
08/15
06:48
08/15/18
06:48

iShares Nasdaq Biotechnology Index: Pivot points, pivot low broken

The following are the pivot points for the iShares Nasdaq Biotechnology Index (IBB). Pivot High: $118.055, Pivot Low: $116.915. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low. At time of writing, price had fallen below the pivot low.

IBB iShares Nasdaq Biotechnology Index
$117.24

0.7 (0.60%)

11/14/17
CANT
11/14/17
NO CHANGE
Target $31
CANT
Overweight
Cantor sees TherapeuticsMD being added to Biotechnology Index on Dec. 15
Cantor Fitzgerald's Tracker Quants team predicts TherapeuticsMD (TXMD) will be added to the Nasdaq Biotechnology Index (IBB) on December 15 and that passive trackers will need to buy 34.5M shares of the company. This may provide additional share upside in the short term, Cantor analyst William Tanner tells investors in a research note. He reiterates an Overweight rating on TherapeuticsMD while trimming his price target for the shares to $31 from $32. The women's healthcare company closed yesterday up 23c to $5.90. Tanner continues to believe TherapeuticsMD's TX-004 will be an important new therapy for vulvar vaginal atrophy.
04/02/18
JEFF
04/02/18
NO CHANGE
JEFF
Buy
Alnylam weakness on Pfizer data a buying opportunity, says Jefferies
Jefferies analyst Maury Raycroft noted that Alnylam (ALNY) fell by over 8% on Thursday after Pfizer (PFE) announced that the phase 3 ATTR-ACT trial assessing tafamidis in TTR-CM met its primary endpoint and that Alnylam shares are trailing the iShares Nasdaq Biotechnology Index (IBB) again today. While he thinks the tafamidis data provide important clinical outcome results that support the need for treatment and benefit in TTR-CM, he also continues to believe the benefits of knocking down/depleting TTR in earlier-stage patients, as Alnylam's patisiran is meant to do, will lead to better objective improvements, Raycroft tells investors. The analyst, who recommends investors buy Alnylam amid the weakness, keeps a Buy rating on the stock.

TODAY'S FREE FLY STORIES

PBI

Pitney Bowes

$7.02

(0.00%)

, Z

Zillow

$35.03

(0.00%)

09:40
02/22/19
02/22
09:40
02/22/19
09:40
Options
Unusually active option classes on open February 22nd »

Unusual total active…

PBI

Pitney Bowes

$7.02

(0.00%)

Z

Zillow

$35.03

(0.00%)

DBX

Dropbox

$25.58

(0.00%)

W

Wayfair

$117.14

(0.00%)

ROKU

Roku

$51.47

(0.00%)

BIDU

Baidu

$171.72

(0.00%)

IQ

iQIYI

$22.76

(0.00%)

MDLZ

Mondelez

$48.39

(0.00%)

NEM

Newmont Mining

$35.39

(0.00%)

NIO

NIO Inc.

$7.62

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

  • 03

    Mar

  • 05

    Mar

  • 06

    Mar

  • 06

    Mar

  • 07

    Mar

  • 11

    Mar

  • 20

    Mar

  • 25

    Mar

  • 28

    Mar

  • 28

    May

SID

CSN

09:38
02/22/19
02/22
09:38
02/22/19
09:38
Upgrade
CSN rating change  »

CSN upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KHC

Kraft Heinz

$48.19

-0.05 (-0.10%)

09:38
02/22/19
02/22
09:38
02/22/19
09:38
Downgrade
Kraft Heinz rating change  »

Kraft Heinz downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FEYE

FireEye

$16.56

-0.105 (-0.63%)

09:37
02/22/19
02/22
09:37
02/22/19
09:37
Conference/Events
House Committee on Homeland Security to hold a hearing »

The Cybersecurity,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 04

    Mar

  • 05

    Mar

MGLN

Magellan Health

$70.81

-1.6 (-2.21%)

09:36
02/22/19
02/22
09:36
02/22/19
09:36
Hot Stocks
Magellan Health says will consider Starboard Value director nominees »

Magellan Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

EHTH

eHealth

$65.58

-0.28 (-0.43%)

09:36
02/22/19
02/22
09:36
02/22/19
09:36
Recommendations
eHealth analyst commentary  »

eHealth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

NXTM

NxStage Medical

$30.00

0.005 (0.02%)

, FMS

Fresenius Medical

$39.83

-0.06 (-0.15%)

09:33
02/22/19
02/22
09:33
02/22/19
09:33
Hot Stocks
NxStage Medical takeover by Fresenius Medical effective Feb. 21 »

NxStage Medical (NXTM)…

NXTM

NxStage Medical

$30.00

0.005 (0.02%)

FMS

Fresenius Medical

$39.83

-0.06 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

KHC

Kraft Heinz

$48.19

-0.05 (-0.10%)

09:33
02/22/19
02/22
09:33
02/22/19
09:33
Downgrade
Kraft Heinz rating change  »

Kraft Heinz downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

$17.76

0.12 (0.68%)

09:31
02/22/19
02/22
09:31
02/22/19
09:31
Recommendations
Wendy's analyst commentary  »

Wendy's shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

ROKU

Roku

$51.47

-2.16 (-4.03%)

09:31
02/22/19
02/22
09:31
02/22/19
09:31
Recommendations
Roku analyst commentary  »

Roku price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOS

Mosaic

$33.17

-0.29 (-0.87%)

09:30
02/22/19
02/22
09:30
02/22/19
09:30
Downgrade
Mosaic rating change  »

Mosaic downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 28

    Mar

  • 28

    May

BJRI

BJ's Restaurants

$51.97

0.75 (1.46%)

09:28
02/22/19
02/22
09:28
02/22/19
09:28
Recommendations
BJ's Restaurants analyst commentary  »

BJ's Restaurants…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTD

Trade Desk

$150.18

0.07 (0.05%)

09:25
02/22/19
02/22
09:25
02/22/19
09:25
Recommendations
Trade Desk analyst commentary  »

Trade Desk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 06

    Mar

VZ

Verizon

$56.14

0.35 (0.63%)

09:25
02/22/19
02/22
09:25
02/22/19
09:25
Recommendations
Verizon analyst commentary  »

5G financial impact…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 03

    Mar

  • 03

    Mar

  • 11

    Mar

GBT

Global Blood Therapeutics

$50.04

-0.45 (-0.89%)

09:25
02/22/19
02/22
09:25
02/22/19
09:25
Conference/Events
Global Blood Therapeutics participates in a conference call with JPMorgan »

Biotech Analyst Kasimov…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

09:25
02/22/19
02/22
09:25
02/22/19
09:25
Conference/Events
UBS services analyst to hold an analyst/industry conference call »

Services Analyst Geiger,…

09:25
02/22/19
02/22
09:25
02/22/19
09:25
Conference/Events
UBS technology analyst to hold an analyst/industry conference call »

Technology Analyst…

EXPGY

Experian

$0.00

(0.00%)

, EFX

Equifax

$110.51

2.61 (2.42%)

09:24
02/22/19
02/22
09:24
02/22/19
09:24
Conference/Events
House Financial Services Committee to hold a hearing »

The Committee holds a…

EXPGY

Experian

$0.00

(0.00%)

EFX

Equifax

$110.51

2.61 (2.42%)

TRU

TransUnion

$63.16

0.2 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

QTS

QTS Realty Trust

$43.52

-0.78 (-1.76%)

09:21
02/22/19
02/22
09:21
02/22/19
09:21
Hot Stocks
QTS Realty Trust raises quarterly dividend to 44c from 41c per share »

Payable on April 4 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 11

    Mar

  • 09

    May

DDAIF

Daimler AG

$0.00

(0.00%)

, PCAR

Paccar

$69.18

0.17 (0.25%)

09:20
02/22/19
02/22
09:20
02/22/19
09:20
Hot Stocks
EU commercial vehicle registrations up 6.2% in January »

In January, the EU market…

DDAIF

Daimler AG

$0.00

(0.00%)

PCAR

Paccar

$69.18

0.17 (0.25%)

CNHI

CNH Industrial

$10.67

0.04 (0.38%)

NAV

Navistar

$37.95

0.3697 (0.98%)

CMI

Cummins

$154.05

-0.18 (-0.12%)

ALSN

Allison Transmission

$49.66

0.07 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ANIK

Anika Therapeutics

$40.45

0.45 (1.13%)

09:18
02/22/19
02/22
09:18
02/22/19
09:18
Recommendations
Anika Therapeutics analyst commentary  »

Anika Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDCE

PDC Energy

$38.74

-0.51 (-1.30%)

09:18
02/22/19
02/22
09:18
02/22/19
09:18
Hot Stocks
PDC Energy issues statement on Kimmeridge 13D filing »

PDC Energy issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

SPX

S&P 500

$0.00

(0.00%)

09:18
02/22/19
02/22
09:18
02/22/19
09:18
Options
Overnight activity included 196 trades in SPX »

196 trades were executed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OLED

Universal Display

$118.31

-0.57 (-0.48%)

09:17
02/22/19
02/22
09:17
02/22/19
09:17
Recommendations
Universal Display analyst commentary  »

Universal Display price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$138.85

-1.44 (-1.03%)

, XRX

Xerox

$31.34

0.47 (1.52%)

09:16
02/22/19
02/22
09:16
02/22/19
09:16
Periodicals
EU may retaliate against Caterpillar, Xerox 'if Trump hits cars,' Bloomberg says »

According to a report out…

CAT

Caterpillar

$138.85

-1.44 (-1.03%)

XRX

Xerox

$31.34

0.47 (1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.